KM Transderm Ltd. has developed adhesive polymer technology for transdermal formulations based on Kaneka’s traditional core technology, polymer compounding. We can control the adhesive performance quite flexibly with this technology. Utilizing strong network with leading pharmaceutical companies, KM Transderm pursues patient-friendly medical products which can contribute to improve the QOL of patients, and that is required at medical fields.